Search research articles
Contact Us
Filters
Showing results (1-10 of 50) with videos related to
Page
of 5
Sort By:
Gastroenterologia Y Hepatologia
|
August 19, 2007
[Probiotics and prebiotics in inflammatory bowel disease]
Natalia Borruel
Nature Reviews. Gastroenterology & Hepatology
|
August 22, 2012
The gut microbiota in IBD
Chaysavanh Manichanh, Natalia Borruel, Francesc Casellas, et al.
Frontiers in Medicine
|
July 18, 2022
Co Treatment With Biologic Agents and Immunotherapy in the Setting of irAEs of Difficult Management
Virginia Robles-Alonso, Fernando Martínez-Valle, Natalia Borruel
Revista Espanola De Enfermedades Digestivas
|
May 11, 2013
Vaccination of patients with inflammatory bowel disease. Practical recommendations
Magda Campins, Yolima Cossio, Xavier Martínez, et al.
Revista Espanola De Enfermedades Digestivas
|
November 1, 2014
Treatment preferences of patients with Crohn's disease: Development of the IMPLICA questionnaire
Natalia Borruel, Javier Castro, Sabino Riestra, et al.
Frontiers in Medicine
|
March 20, 2023
JAK inhibitors: A new dawn for oral therapies in inflammatory bowel diseases
Claudia Herrera-deGuise, Xavier Serra-Ruiz, Ernesto Lastiri, et al.
Inflammatory Bowel Diseases
|
April 9, 2016
Iron Deficiency in the Absence of Anemia Impairs the Perception of Health-Related Quality of Life of Patients with Inflammatory Bowel Disease
Claudia Herrera-deGuise, Francesc Casellas, Virginia Robles, et al.
International Journal of Molecular Sciences
|
September 23, 2022
Intercontinental Gut Microbiome Variances in IBD
Luis Mayorga, Gerard Serrano-Gómez, Zixuan Xie, et al.
Revista Espanola De Enfermedades Digestivas
|
February 4, 2012
Effect upon hospital activity of the application of a continued care model centered on patients with inflammatory bowel disease
Francesc Casellas-Jordá, Natalia Borruel-Sainz, Antonio Torrejón-Herrera, et al.
Journal of Gastroenterology and Hepatology
|
October 11, 2014
Predictive value of early restoration of quality of life in Crohn's disease patients receiving antitumor necrosis factor agents
Claudia Herrera-deGuise, Francesc Casellas, Virginia Robles, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 50) with videos related to
Sort By:
Page
of 5
Gastroenterologia Y Hepatologia
|
August 19, 2007
[Probiotics and prebiotics in inflammatory bowel disease]
Natalia Borruel
Nature Reviews. Gastroenterology & Hepatology
|
August 22, 2012
The gut microbiota in IBD
Chaysavanh Manichanh, Natalia Borruel, Francesc Casellas, et al.
Frontiers in Medicine
|
July 18, 2022
Co Treatment With Biologic Agents and Immunotherapy in the Setting of irAEs of Difficult Management
Virginia Robles-Alonso, Fernando Martínez-Valle, Natalia Borruel
Revista Espanola De Enfermedades Digestivas
|
May 11, 2013
Vaccination of patients with inflammatory bowel disease. Practical recommendations
Magda Campins, Yolima Cossio, Xavier Martínez, et al.
Revista Espanola De Enfermedades Digestivas
|
November 1, 2014
Treatment preferences of patients with Crohn's disease: Development of the IMPLICA questionnaire
Natalia Borruel, Javier Castro, Sabino Riestra, et al.
Frontiers in Medicine
|
March 20, 2023
JAK inhibitors: A new dawn for oral therapies in inflammatory bowel diseases
Claudia Herrera-deGuise, Xavier Serra-Ruiz, Ernesto Lastiri, et al.
Inflammatory Bowel Diseases
|
April 9, 2016
Iron Deficiency in the Absence of Anemia Impairs the Perception of Health-Related Quality of Life of Patients with Inflammatory Bowel Disease
Claudia Herrera-deGuise, Francesc Casellas, Virginia Robles, et al.
International Journal of Molecular Sciences
|
September 23, 2022
Intercontinental Gut Microbiome Variances in IBD
Luis Mayorga, Gerard Serrano-Gómez, Zixuan Xie, et al.
Revista Espanola De Enfermedades Digestivas
|
February 4, 2012
Effect upon hospital activity of the application of a continued care model centered on patients with inflammatory bowel disease
Francesc Casellas-Jordá, Natalia Borruel-Sainz, Antonio Torrejón-Herrera, et al.
Journal of Gastroenterology and Hepatology
|
October 11, 2014
Predictive value of early restoration of quality of life in Crohn's disease patients receiving antitumor necrosis factor agents
Claudia Herrera-deGuise, Francesc Casellas, Virginia Robles, et al.
Page
of 5